Juluca Is the Latest Once-Daily Combo Med for HIV

February 2018

Juluca (jah-LOO-kah) will be a new two-drug combo for HIV.

It combines 50 mg of dolutegravir (Tivicay) and 25 mg of rilpivirine (Edurant) in a once-daily tablet.

Expect Juluca to be used for patients who've been on a stable regimen for at least six months...especially if they can't tolerate certain HIV meds or need fewer pills per day.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Hospital Practice Act Fast When Dantrolene Is Needed for Malignant Hyperthermia
Med Histories Use Strategies to Hone Your Med History Skills
Analgesics Avoid Dangerous Mishaps With Local Anesthetics
Salt Forms Know Your Way Around Salt Forms
Med Safety Expect to See Less Use of Injectable Promethazine
Kidney Disease Think of Etelcalcetide as an IV Alternative to Cinacalcet
Critical Care You May Be Surprised by Meds Used in Targeted Temperature Management Protocols
HIV & AIDS Juluca Is the Latest Once-Daily Combo Med for HIV
Supplements Document Details of Supplement Use on Med Histories
Travel Medicine Be Aware of Treatments for Altitude Sickness
Diabetes Meds Know How Bydureon BCise, Ozempic, and Steglatro Compare to Other Diabetes Meds

Juluca Is the Latest Once-Daily Combo Med for HIV

Get unlimited access through an Enterprise license

Table of Contents